Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population
Authors:
- Yuya MatsueYMYuya Matsue
- Makoto SuzukiMSMakoto Suzuki
- Mie SeyaMSMie Seya
- Ryota IwatsukaRIRyota Iwatsuka
- Akira MizukamiAMAkira Mizukami
- Wataru NagahoriWNWataru Nagahori
- Masakazu OhnoMOMasakazu Ohno
- Akihiko MatsumuraAMAkihiko Matsumura
- Yuji HashimotoYHYuji Hashimoto
- 1 February 2013
- journal article
- Published by Elsevier in Journal of Cardiology
- Vol. 61 (2) , 169-174
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Heart Failure, Chronic Kidney Disease, and Biomarkers - An Integrated Viewpoint -Circulation Journal, 2010
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Loop Diuretics in Acute Decompensated Heart FailureCirculation: Heart Failure, 2009
- Epidemiology of Chronic Kidney Disease in Heart FailureHeart Failure Clinics, 2008
- Prognostic Value of Transient and Sustained Increase in In-Hospital Creatinine on Outcomes of Patients Admitted With Acute Coronary SyndromeThe American Journal of Cardiology, 2007
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart FailureCirculation, 2006
- Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarctionAmerican Heart Journal, 2005
- Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failureThe American Journal of Cardiology, 2000
- Hormones and Hemodynamics in Heart FailureNew England Journal of Medicine, 1999